A New Remedy For Impotence

Zonagen (ZONA) is a stock you wish you had stumbled upon earlier this year, when it was trading at 13. It has since scooted up to 33, thanks to its anti-impotence pill, which recently completed its third round of human trials.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.